Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

17
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
17
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

63
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
63
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

16
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
16
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

153
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
153
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

69
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
69

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tricuspid annular diameter as a predictor of persistent significant tricuspid regurgitation following transcatheter atrial septal defect closure: A prospective single center study.

Kardiologia polska·2026
Same author

Plasma Metabolomic Signature Predicting Deviation from Healthy Vascular Aging in Two European Cohorts.

Pulse (Basel, Switzerland)·2026
Same author

Intra- and inter-rater reproducibility of the echocardiographic data of the Nigerian UPRIGHT-HTM trial participants.

Cardiovascular journal of Africa·2026
Same author

A Coupled Inflammatory-Fibrotic-Nitrosative Axis in Patients with Patent Foramen Ovale and Cryptogenic Stroke.

Journal of clinical medicine·2026
Same author

Prognostic Value of Left Atrial Strain for Atrial Fibrillation After Cryptogenic Stroke and Embolic Stroke of Undetermined Source.

Cardiology in review·2026
Same author

Radiofrequency current-facilitated implantation of left bundle branch pacing lead for cardiac resynchronization therapy.

Heart rhythm·2026

Related Experiment Video

Updated: Oct 14, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.6K

OBESITY AND ATRIAL FIBRILLATION - BARIATRIC SURGERY AS A METHOD OF AF RISK DECREASE.

Anna Krakowiak1, Marek Rajzer2, Mateusz Gaczoł2

  • 1DEPARTMENT OF CARDIAC AND VASCULAR DISEASES, JOHN PAUL II HOSPITAL, KRAKOW, POLAND.

Wiadomosci Lekarskie (Warsaw, Poland : 1960)
|November 2, 2021
PubMed
Summary

Obesity is a global epidemic linked to atrial fibrillation (AF). Managing obesity, including through bariatric surgery, can reduce AF risks and complications in patients.

Keywords:
atrial fibrillationbariatric surgerydiabetesmetabolic syndromeobesityobstructive sleep apnea

More Related Videos

Sleeve Gastrectomy in Mice using Surgical Clips
05:16

Sleeve Gastrectomy in Mice using Surgical Clips

Published on: November 14, 2020

6.8K
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

83.9K

Related Experiment Videos

Last Updated: Oct 14, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.6K
Sleeve Gastrectomy in Mice using Surgical Clips
05:16

Sleeve Gastrectomy in Mice using Surgical Clips

Published on: November 14, 2020

6.8K
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

83.9K

Area of Science:

  • Cardiology
  • Metabolic Diseases
  • Public Health

Background:

  • Obesity is a global epidemic, contributing to cardiovascular diseases like hypertension, ischemic heart disease, and arrhythmias.
  • Atrial fibrillation (AF) affects 1-2% of the general population, with overweight and obesity present in 25% of AF patients.
  • Excessive adipose tissue plays a significant role in the pathophysiology linking obesity to AF.

Purpose of the Study:

  • To explore the relationship between obesity and atrial fibrillation (AF).
  • To discuss the pathophysiology of obesity concerning AF, diabetes, obstructive sleep apnea, and metabolic syndrome.
  • To evaluate the benefits of bariatric surgery in managing AF in obese patients.

Main Methods:

  • Review of existing literature on obesity, cardiovascular diseases, and atrial fibrillation.
  • Analysis of the pathophysiological links between excessive adipose tissue and cardiac arrhythmias.
  • Examination of the role of bariatric surgery in AF management.

Main Results:

  • Obesity is a major risk factor for cardiovascular diseases, including AF.
  • Obesity is intricately linked with conditions like diabetes, obstructive sleep apnea, and metabolic syndrome, all associated with AF.
  • Bariatric surgery shows potential benefits for qualifying patients with AF.

Conclusions:

  • Careful assessment of paroxysmal AF and risk factors is crucial for patients undergoing bariatric surgery.
  • Appropriate diagnosis enables effective anticoagulant prophylaxis, significantly reducing complication rates.
  • Comprehensive preoperative and postoperative care, including antiarrhythmic, respiratory, and metabolic therapy, is recommended.